TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,483,000 | +269.9% | 426,054 | +104.2% | 0.32% | +279.8% |
| Q2 2021 | $2,023,000 | +18.3% | 208,653 | +31.1% | 0.08% | +20.0% |
| Q1 2021 | $1,710,000 | -61.2% | 159,108 | -46.8% | 0.07% | -58.3% |
| Q4 2020 | $4,403,000 | +173.6% | 299,324 | +164.5% | 0.17% | +118.2% |
| Q3 2020 | $1,609,000 | +0.2% | 113,185 | -43.0% | 0.08% | -15.4% |
| Q2 2020 | $1,606,000 | +105.1% | 198,600 | +2.5% | 0.09% | +46.8% |
| Q1 2020 | $783,000 | – | 193,769 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |